Skip to main content

Table 9 Serum Leptin levels: effectiveness of treatments

From: The use of LeptiCore® in reducing fat gain and managing weight loss in patients with metabolic syndrome

 

Leptin (mean mg/dl)

change (%)

 

Initial

8 Weeks

8 Weeks - Initial

Formula B (↑dose)

30.15 ± 1.50

15.83 ± 1.13b

-47.59‡

Formula A (↓dose)

31.52 ± 1.21

16.72 ± 1.40a

-46.95‡

Placebo

30.33 ± 1.63

25.97 ± 1.61

-14.38

  1. ap < 0.05; bp < 0.001 compared with Placebo
  2. *p < 0.05; **p < 0.001; compared with Formula A
  3. †p < 0.05; ‡p < 0.001 compared with Initial; intragroup analysis
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X